THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key Tovaxin® data at the upcoming American Academy of Neurology (AAN) 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.
